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ABSTRACT  
Objective: Study physicochemical properties and activity of biotechnological drugs coating lactose particles in fluidized beds for the development of 
a prospective approach of their identification. 
Methods: Lactose monohydrate as pharmaceutical excipient; affinity-purified polyclonal rabbit antibodies to recombinant human interferon-
gamma as a drug substance; Pilotlab fluid bed apparatus was used for lactose powder saturation with solutions of pharmaceutical substances to the 
point of granulation (pelletizing); inverse light scattering method (2D-LS) for analysis of micron vibrations frequency spectra of samples surfaces 
for light intensity distribution in time by values of d1, d2, d3 primary descriptors; low angel and dynamic laser light scattering (LALLS, DLS) 
methods for distribution of lactose-water (LW) supramolecular complexes into volume fractions (micron "size spectra"), using the Master Sizer 
2000 instrument and Zeta Sizer Nano ZS instrument in the nanoscale; Spirotox method for research of biological activity to determine the activation 
energy (Ea) values of cell death in solutions of tested samples.  
Results: Changes in 2D-LS scattering time on sample surfaces, described by topological descriptors, made it possible to clearly differentiate the 
intact lactose from fluidized samples by specific corridors in coordinates di=F(t). The calculated activation energy (Ea) values of cell biosensor death 
process in solutions of drugs coating lactose allow to characterize the biological activity of it in the initial (by Ea increase) and activated state (by Ea 
decrease) after the creation of intra-laboratory transmucosal conditions. A unique dimensional spectrum of LW complexes in the nanoscale range 
was obtained by DLS. The differences between samples in the distribution of LW complexes in the size range from 1 µm to 125 µm was showed by 
LALLS. 
Conclusion: The developed approach, including Сhemometrics, laser and biotesting methods can be used for qualitative the analysis tasks as well 
as for analytical control of the fluidization process in cases where identifiable pharmaceutical substances are not distinguishable by traditional 
analytical methods.  
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INTRODUCTION 
In the epoch of a sharp rise in industrial volumes of drug production, 
the process of "homogeneity" of its creation with necessary functional 
characteristics acquires special importance [1, 2]. The pharmaceutical 
and technological aspect of the quality of coating of solid dosage forms 
is of great importance, which is the final operation in the drug 
production. The quality and marketability of pharmaceutical products, 
decomposition, dissolution as well as modeled active pharmaceutical 
ingredient (API) release and achievement of maximum therapeutic 
efficiency depend on the way it is organized. At modern 
pharmaceutical manufactures for application of coatings on firm 
medical products (powders, pills, dragee) fluidized bed (FB) devices 
were used, which work is based on laws of hydrodynamics and heat 
exchange in dispersed mediums [3-5].  
Fluidization consists in the rapid formation of isolated droplets of a 
drug substance in the transport flow of liquids ‒ a type of reaction 
micro-cameras [6]. Droplet formation begins the penetration of the 
dispersed phase into the channel with a continuum phase. There are 
forces influencing the droplet formation at the interface. Balance and 
correlation of these forces determine the processes of interaction of 
two flows [7, 8]. Examples of hydrodynamic forces are the wall 
repulsion force (F wall) originating from the asymmetry of the 
vorticity around the particles, pushing the particles away from the 
wall, and the shear-gradient lift force (F shear) originating from the 
curvature of the shear flow profile, which leads the particles to migrate 
away from the central axis [9]. Due to the competition between these 
two forces, particles suspended in the fluid migrate across streamlines 
when flowing downstream, and finally equilibrate at a specific location 
in the channel’s cross-section (fig. 1). 
 
Fig. 1: Schematic illustration of the forces on a suspended 
particle and the equilibrium position of the particle in a fully 
developed flow in a confined channel [10] 
 
One of the main parameters determining the properties of fluid 
systems is the Randol’s Number at Re<2000-the laminar and mass 
transfer flow is determined by diffusion. Such conditions allow 
effective mixing of liquid flows [11].  
Reducing the transverse channel accelerates mixing and controls the 
flow of liquids in space and time. The activation of solid and liquid 
systems leads to changes in their physical and chemical properties, 
reactivity and other properties. Analytical systems implementing the 
described technological capabilities were named "microfluidics, 
nanofluidics and lab-on-a-chip science and technology" [12]. The 
concept of compartmentalization of chemical reactions (reactions 
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that take place in small, isolated volumes) is effectively applied in 
pharmaceutical production to create innovative drugs of directional 
and modified action [13]. Therapeutically, innovative drugs provide 
an advantage over existing methods of treatment in the case, for 
example, of relatively low doses when the desired effect is achieved, 
or when a drug contains substances of biotechnological origin-
antibodies to specific antigen targets [14]. In recent years antibody 
preparations have found wide application in medicine due to 
targeting of pathophysiological causes of infectious, autoimmune, 
oncological and other socially significant diseases [15-18]. Taking 
into account the current world situation with regard to the rapid 
spread of respiratory infection, the development of new drugs aimed 
at targets important for virus reproduction as well as specific 
methods of quality control is relevant [19, 20].  
The purpose of the present work is to study the physical-chemical 
properties and activity of biotechnological drugs based on lactose 
diluent in comparison with placebo obtained under conditions of 
fluidization in order to develop a perspective method of quality 
control by "identification" parameter.  
MATERIALS AND METHODS 
In this work, Lactose monohydrate (SuperTabR30GR) is presented 
in a variety of forms, including excipient, tablet diluent, capsules, 
powders (DMV-Fonterra Excipients GmbH and Co. KG, Norten 
Hardenberg, Germany) (fig. 2) [21]. Diluents are used to ensure the 
necessary mass of the tablet if the composition contains a small 




Fig. 2: Structural for monohydrate lactose 
 
Fluidized bed granulation 
The following process of granulation in a fluidized bed consisted of 
mixing lactose powder in a suspended layer with subsequent 
moistening with water-alcohol solutions of medicinal substances 
while the mixing continued. Pelletizing centers in fine powder are 
granulation liquid droplets or dispersed particles containing active 
centers with excessive energy (fig. 3) [27, 28]. 
 
 
Fig. 3: Direct granulation process [29] 
 
Drugs preparation 
Affinity-purified polyclonal rabbit antibodies (Abs) to recombinant 
human interferon-gamma (IFNg) were manufactured by Angel 
Biotechnology Holdings plc (Edinburgh, UK). Buffer solution of 
antibodies to IFNg (2.5 mg/ml) was mixed with a solvent (ethanol-
water solution) by using a microfluid analytical system with 1000 µl 
flow chip-microreactor (Syrris Ltd, UK) to produce dilutions according 
to the technology described in the US patent 8 535 664 (31) [24]. In 
the case of the placebo, the solvent was used to prepare samples of 
the buffer instead of Abs to IFNg following the method described 
above (a buffer solution which is equivalent to the vehicle for Abs to 
IFNg [25]. Lactose monohydrate powder was saturated with 
solution Abs to IFNg and placebo on a Pilotlab fluid bed apparatus 
(Hüttlin GmbH, Schopfheim, Germany) to the point of granulation 
(pelletizing) [26].  
Methods of research 
Spirotox method 
Research of biological drug activity was carried out with the use of 
test culture Spirostomum ambiguum, characterized by statistically 
reliable sensitivity to toxicants [30, 31]. The kinetic scheme of 
ligand-induced death of S. ambiguum includes the interaction state 
(Сcell+nL), the intermediate state (C-Ln) and the state of transition to 
the cell dead (DC), determining the ligand-receptor interaction 
rate (fig. 4).  
 
 
Fig. 4: Kinetic scheme of ligand-receptor interaction S. 
ambiguum with toxicant 
 
The dependence of lifetime on temperature is linearized in "Arrenius 
coordinates" [32, 33]: 




The analysis of occurrence frequency spectra of micron vibrations 
of the sample's surface was carried out by 2D-LS inverse dynamic 
light scattering method using the developed installation and 
original software, based on the definition of topological 
descriptors dependences on time [34]. For the analysis of low-
frequency micro oscillations of drugs, a portable optical 
microscope was used and was connected to a personal computer 
USB-camera. The obtained interference patterns were 
mathematically processed with the help of three descriptors 
(criteria of difference), which reflect their degree of difference and 
allow estimating them quantitatively Vidan® software was used 
for data processing [35, 36].  
Laser scattering methods were used to characterize the 
supramolecular dispersion of samples by the distribution of clusters 
into volume fractions ("size spectra"), using the Master Sizer 2000 
instrument and Zeta Sizer Nano ZS instrument (MALVERN 
Instruments, UK) [37]. 
Temperature activation of the powders under study was carried out 
using a solid-state thermostat for 15 min at 37 ˚C [38, 39]. 
Statistics  
The findings were processed by the statistical methods using 
software packages of Origin Pro 9.1. Each value on the fig. 
represents "mean±SD", significant differences were considered 
when p<0.05. 
RESULTS  
The process of preparation of drug solutions by fluidization method 
is accompanied by the following physical and chemical processes: 
addition of solvent portions, a decrease of initial substance content, 
hydrodynamic processes connected with mixing, the interaction of 
components with each other and with capillary tube's surface, the 
appearance of new active centers, energy changes [40-42]. As a 
result, the properties of the complex system "solvent active 
pharmaceutical ingredient" change and differ from the original 
substance [43-45].  
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2D-LS method 
The surface of pharmaceutical substances is a unique characteristic and 
its properties depend on the chemical nature of the analyzed object and 
the peculiarities of synthesis. The results of the 2D distribution of 
scattered light intensity in time by values d1, d2, d3 of primary descriptors 
reflecting micron vibrations on the surface are presented in fig. 5. 
 
 
A      B      C 
 
Fig. 5: Evaluation of the 2D light scattering patterns (LS) of drugs coating lactose as functions di=F(t). A-Intact lactose (lactose monohydrate 
SuperTabR30GR); B-FB placebo drug (lactose with buffer solution); C-FB drug (lactose with solution Abs to IFNg) (n≥50, p<0.05) 
 
 
Changes in 2D light scattering time of specimen surfaces described 
with topological descriptors di =F(t) made it possible to determine 
definitely the intact lactose sample (fig. 5A), which hadn’t been 
involved in the process of fluidization as a result of the form 
individual " corridors" in di=F(t) coordinates. For differentiation of 
drugs after lactose coating in the fluidized bed, we used the analysis 
of the frequency composition of the measured 2D-LS signal based on 
Fourier transform (fig. 6).  
 
 
Fig. 6: Fourier transformation of 2D-LS sample measurement 
results, Black-FB placebo drug (lactose with buffer solution); 
Blu-FB drug (lactose with solution Abs to IFNg) (n≥50, p<0.05) 
 
It should be noted that identifying drug substances are chemically 
indistinguishable, but their spatial structure is the basis for the 
observed specificity of 2D light scattering.  
Spirotox-test 
Recently we have established the dependence of death kinetics of S. 
ambiguum on temperature (fig. 7) [46]. The activation energy (Ea) 
values of cell biosensor death process in solutions of drugs were 
assessed. 
 



























Fig. 7: Dependence of a cellular biosensor lifetime on 
temperature in 6% solutions of lactose monohydrate in water 
(n=5, p<0.05); the graph includes an Arrhenius plot 
 
The existence of the intermediate state (fig. 4) in the process of the 
test object death means that the death of the cell should take place 
while activating the process of destruction of the cell with the energy 
consumption [47]. Indeed, we established the dependence of the 
kinetics of the death of S. ambiguum on temperature. The change of 
properties was noted by us when comparing the energy values of 
cell transition activation on the example of lactose of intact, 
biotechnologically obtained drug (Abs to IFNg) and placebo drug. 
Based on the physical and chemical interpretation of the activation 
energy, we can conclude that the higher the values of the apparent 
activation energy of cell death, the greater the energy barrier to cell 
death (table 1). 
  
Table 1: Activation energy values of the ligand‒induced death of S. ambiguum in solutions of different lactose samples (n=5, p<0.05) 
Samples Activation energy, kJ/mol 
(  ±SD) 
Cell lifetime, τL, min (6% water solutions, T=297 K) 
( ±SD) 
Intact lactose (lactose monohydrate SuperTabR30GR) 108±5 8.74±0.16 
FB placebo (lactose with buffer solution) 112±5  9.38±0.6 
FB drug (lactose with solution Abs to IFNg)  139±5 10.19±0.12 
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The table demonstrates statistically significant differences in the 
activation energy values of ligand-induced cell death in the solutions 
of the investigated samples represented by the formed specific 
supramolecular lactose-water (LW) complexes. According to our 
data, substances with high biological activity, characterized by low 
cell survival, correspond to low Ea values, which is consistent with 
the low values of toxicity for organisms of a higher hierarchical level 
[48]. 
We used the static and dynamic laser light scattering methods (DLS, 
LALLS) to study the size of LW supramolecular complex distribution 
[49]. Local «inhomogeneities» of the aqueous solution refractive 
index caused by fluctuations in the concentration of aqueous-lactose 
complexes lead to light scattering and the determination of their 
hydrodynamic radius. We have obtained a histogram of particle size 
distribution-a unique dimensional spectrum of water-lactose 
complexes in the nanoscale range (table 2). 
  
Table 2: Distribution of lactose-water (LW) supramolecular complexes by size according to DLS method data (n≥15 p<0.05) 
Drugs coating lactose Peak Size, nm ( ±SD) Size fraction,% 
Intact lactose (lactose monohydrate 
SuperTabR30GR) 
1 268±151 85 
2 1.05±0.2 13 
3 4441±906 2.5 
FB placebo (lactose with buffer solution) 
 
1 202±82 82 
2 1.16±0,2 12 
3 4233±992 5.4 
FB drug (lactose with solution Abs to IFNg) 1 252±125 82 
2 1.07±0.2 12.3 
3 4363±942 6.5 
 
Light scattering by particles less than 1 μm diameter does not 
depend on the nature of the substance. 
Using the physical principle of electromagnetic wave scattering from 
«inhomogeneities» of density, we had measured the angular 
distribution of the intensity of light as the laser beam was passing 
through a cell consecutively filled with different lactose samples. It 
gave us a way to differentiate the drugs under lactose particle coating 



















Fig. 8: Distribution of LW supramolecular complexes by size 
(LALLS method data), 1-Intact lactose; 2-FB placebo; 3-FB drug 
(n≥15, p<0.05) 
 
Distribution of supramolecular LW complexes by size according to 
LALLS method in the FB drug solution is represented by the largest 
size group among comparison samples corresponding to 125 µm. 
The smallest size of supramolecular complexes in the sample of 
intact lactose is 35 μm and 15 μm. Decrease in the scale of 
heterogeneity that determines the characteristic time of mass 
transfer of reagents (ligands and cell receptor) to each other 
contributes to the increase in the reaction rate of their interaction 
state and reduction of activation energy (table 1).  
Structure activation effect of a solid substance 
The study of characteristics of drugs coating lactose obtained by 
fluidization has shown the need to attract new approaches in quality 
assessment. To confirm the above described chemometric and laser 
methods for qualitative analysis and for the analytical control of the 
fluidization process, we have implemented intra-laboratory methods 
for the activation of testing samples. For this purpose, FB drug and 
comparison powders-Intact lactose, FB placebo-were exposed to 
temperature influence, wetting and gentle grinding with the 
subsequent investigation of the proposed methods.   
The activation conditions of samples have been chosen based on the 
advantages of transmucosal (buccal and sublingual) delivery: the rate of 
action associated with high vascularization of mucosal zones, the 
possibility of reducing the therapeutic dosage, no need to drink water, 
the absence of destruction outside of gastrointestinal digestive enzymes 
with efficiency, simplicity and cost-effectiveness of production [50, 51]. 
Thus, using a solid-state thermostat, preliminary crushed samples of 
powders wetted with Mili-Q water were heated to 37 °C within 15 min. 
From the point of view of quantum mechanics representations, the 
selected conditions are well consistent with the mechanisms of 
physical and chemical radiation-free relaxation involving a water 
molecule in the transfer of excitation energy to the surrounding [52]. 
Fig. 9 shows the results demonstrating a decrease in the energy 
barrier of the process of cell death in a row: intact lactose (diluent, 
excipient)-placebo-drug. 
 




















Fig. 9: Energy activation of a cell biosensor death process in 6% 
aqueous solutions of drugs coating lactose. 1-normal 
conditions; 2-conditions of complex influence (temperature, 
moistened, gentle grinding) (n=5, p<0.05) 
 
This can be interpreted as an increase in the biological activity of the 
tested samples as a result of intra-laboratory effects of temperature, 
water addition and dispersion (fig. 9). 
According to [53], the chemical mechanism of radiation-free 
relaxation produces final or intermediate products different from 
the original compounds, which was demonstrated by the 
distribution of LW supramolecular complexes according to photon 
correlation spectroscopy (DLS) data (fig. 10). 
Uspenskaya et al. 
Int J App Pharm, Vol 12, Issue 5, 2020, 272-278 
276 










































A                                                                                                                      B 
Fig. 10: Distribution of LW supramolecular complexes by size (DLS method data), A ‒ before complex influence (temperature, moistened, 
gentle grinding); B–after the condition changes (n≥15, p<0.05).1-Intact lactose; 2-FB placebo; 3-FB drug 
 
As a result, the evidence of conformational mobility of the water-
lactose supramolecular complex affecting its biological activity was 
obtained (fig. 11).  
 
 
Fig. 11: Formation of the LW supramolecula complexes and 
reversible transitions between conformation states (L-Intact 
lactose, W-H2O, LmWn*-FB drug) 
 
It is evident from the scheme that water molecules participate in the 
appearance of additional channels of inducible relaxation and 
contribute to the self-assembly of drug molecules into 
supramolecular complexes [54].  
DISCUSSION 
Lactose is one of the most frequently used pharmaceutical excipient 
for oral formulations. The technology of its saturation with API 
usually involves fluid bed apparatus. This process itself together 
with the complexity of modern drugs, make their challenging 
identification task. It is not only necessary to take into account the 
physical and chemical properties of API, but also the conditions of 
the realization their biological activity. One of the examples of such 
drugs is a drug investigated in our study. Using it, we developed an 
effective approach to investigate properties of biotechnological 
drugs coating lactose in fluid bed given the topicality of the issue 
presented by other researchers [55].  
Changes in 2D-LS scattering time on sample surfaces, described by 
topological descriptors followed by Fourier Transformation, made it 
possible to clearly differentiate the intact lactose from fluidized 
samples by specific corridors in coordinates di=F(t) [56]. The 
calculated Ea values of cell biosensor death process in solutions of 
drugs coating lactose allow to characterize the biological activity of it’s 
in the initial (by Ea increase) and activated state (by Ea decrease) after 
creation of intra-laboratory transmucosal conditions. A unique 
dimensional spectrum of water-lactose complexes in the nanoscale 
range has obtained by DLS. By LALLS we show the difference between 
samples in the distribution of LW complexes in size range from 1 µm 
to 125 µm. Moreover, the results of our study confirmed that in spite of 
drug substance dilution (technological processing of the original 
substance under specific physical conditions) finally produced API 
contains nanosized structures that represents supramolecular 
complexes formed by antibodies and water molecule clusters [57]. 
Intra-laboratory transmucosal conditions proposed for in vitro testing 
of oral drugs should be used for improving the quality of analytical 
tests of complex biotechnological oral drugs. 
CONCLUSION 
The developed approach, including chemometrics, laser and 
Spirotox methods, can be used for qualitative analysis tasks as well 
as for the analytical control of the fluidization process in cases 
where identifiable pharmaceutical substances are not 
distinguishable by traditional analytical methods.  
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